<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR84">
 <label>84.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Busse</surname>
    <given-names>WW</given-names>
   </name>
   <name>
    <surname>Morgan</surname>
    <given-names>WJ</given-names>
   </name>
   <name>
    <surname>Gergen</surname>
    <given-names>PJ</given-names>
   </name>
   <name>
    <surname>Mitchell</surname>
    <given-names>HE</given-names>
   </name>
   <name>
    <surname>Gern</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>AH</given-names>
   </name>
   <name>
    <surname>Gruchalla</surname>
    <given-names>RS</given-names>
   </name>
   <name>
    <surname>Kattan</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Teach</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Pongracic</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Chmiel</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Steinbach</surname>
    <given-names>SF</given-names>
   </name>
   <name>
    <surname>Calatroni</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Togias</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Thompson</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>Szefler</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Sorkness</surname>
    <given-names>CA</given-names>
   </name>
  </person-group>
  <article-title>Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children</article-title>
  <source>N Engl J Med</source>
  <year>2011</year>
  <volume>364</volume>
  <issue>11</issue>
  <fpage>1005</fpage>
  <lpage>1015</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1009705</pub-id>
  <?supplied-pmid 21410369?>
  <pub-id pub-id-type="pmid">21410369</pub-id>
 </element-citation>
</ref>
